Interphase cytogenetics of prostatic tumor progression: Specific chromosomal abnormalities are involved in metastasis to the bone

Laboratory Investigation

Volumn 77, Issue 5, 1997, Pages 437-448

  Alers, Janneke C ^a   Krijtenburg, Pieter Jaap ^a   Rosenberg, Carla ^b,c   Hop, Wim C J ^a   Verkerk, Annet M ^a   Schröder, Fritz H ^a   Van Der Kwast, Theodorus H ^a   Bosman, Fré T ^d   Van Dekken, Herman ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER STAGING; CHROMOSOME 8; CHROMOSOME ABERRATION; GENETIC LINKAGE; HUMAN; IN SITU HYBRIDIZATION; INTERPHASE; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 8; DISEASE PROGRESSION; DNA, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION; INTERPHASE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PROSTATIC NEOPLASMS;

EID: 0030695041     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, and Jenkins RB (1994). Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 54:3998-4002.
2. Alers JC, Krijtenburg P-J, Vissers KJ, Bosman FT, van der Kwast ThH, and van Dekken H (1995a). Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: Analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chromosom Cancer 12:241-250.
3. Alers JC, Krijtenburg P-J, Vissers CJ, Bosman FT, van der Kwast ThH, and van Dekken H (1995b). Cytogenetic heterogeneity and histologic tumor growth patterns in prostatic cancer. Cytometry 21:84-94.
4. Alers JC, Krijtenburg P-J, Vissers KJ, Krishnadath SK, Bosman FT, and van Dekken H (1995c). Interphase in situ hybridization to disaggregated and intact tissue specimens of prostatic adenocarcinoma. Histochem Cell Biol 104:479-486.
5. Alers JC and van Dekken H (1996). Interphase cytogenetic analysis of solid tumors by non-isotopic DNA in situ hybridization. Progr Histochem Cytochem 31:1-137.
6. Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, and Kastendieck H (1993). Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet 66:93-99.
7. Atkin NB (1986). Chromosome 1 aberrations in cancer. Cancer Genet Cytogenet 21:279-285.
8. Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, von Eschenbach AC, Chung LWK, and Liang JC (1994). Trisomy 7: A potential cytogenetic marker of human prostate cancer progression. Genes Chromosom Cancer 9:19-27.
9. Barreton GB, Valina C, Vogt T, Schneiderbanger K, Diebold J, and Löhrs U (1994). Interphase cytogenetic analysis of prostatic carcinomas by use of nonisotopic in situ hybridization. Cancer Res 54:4474-4480.
10. Bova GS, Carter BS, Bussemakers MJG, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, and Isaacs WB (1993). Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53:3869-3873.
11. Brothman AR, Peehl DM, Patel AM, and McNeal JE (1990). Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 50:3795-3803.
12. Brown JA, Alcaraz A, Takahashi S, Persons DL, Lieber MM, and Jenkins RB (1994). Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma. J Urol 152:1157-1162.
13. Carter HB and Coffey DS (1990). Prostate cancer: An increasing medical problem. Prostate 16:39-48.
14. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, and Jensen RH (1996). Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102.
15. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, and Jensen RH (1994). Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosom Cancer 11:153-162.
16. Cooney KA, Wetzel JC, Meravjer SD, Macoska JA, Singleton TP, and Wojno KJ (1996). Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res 56:1142-1145.
17. Deitch AD and deVere White RW (1992). Flow cytometry as a predictive modality in prostate cancer. Hum Pathol 23:352-359.
18. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Lioatta LA, and Linehan WM (1995). Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 55:2959-2962.
19. Gao X, Zacharek A, Grignon DJ, Sakr W, Powell IJ, Porter AT, and Honn KV (1995). Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer. Oncogene 11:1241-1247.
20. Gervasi LA, Mata J, Easley JD, Wilbanks JH, Seale-Hawkins C, Carlton CE Jr, and Scardino PT (1989). Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 142:332-336.
21. Gittes RF (1991). Carcinoma of the prostate. N Engl J Med 324:236-245.
22. Gleason DF (1992). Histologic grading of prostate cancer. Hum Pathol 23:273-279.
23. Gray IC, Philips SMA, Lee SJ, Neoptolemos JP, Weissenbach J, and Spurr NK (1995). Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 55:4800-4803.
24. Isaacs WB, Bova GS, Morton RA, Bussemakers MJG, Brooks JD, and Ewing CM (1995). Molecular biology of prostate cancer progression. Cancer Surv 23:19-32.
25. Isola J, DeVries S, Chu L, Ghazvini S, and Waldman F (1994). Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 145:1301-1308.
26. Jenkins RB, Qian J, Lieber MM, and Bostwick DG (1997). Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 47:524-531.
27. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, and Pinkel D (1992). Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
28. Kunimi K, Bergerheim USR, Larsson I-L, Ekman P, and Collins VP (1991). Allelotyping of human prostatic adenocarcinoma. Genomics 11:530-536.
29. Latil A, Baron J-C, Cussenot O, Fournier G, Soussi T, Boccon-Gibod L, Le Duc A, Rouëssé J, and Lidereau R (1994). Genetic alterations in localized prostate cancer: Identification of a common region of deletion on chromosome arm 18q. Genes Chromosom Cancer 11:119-125.
30. Lerner SP, Seale-Hawkins C, Carlton CE, and Scardino PT (1991). The risk of dying of prostate cancer in patients with clinically localized disease. J Urol 146:1040-1035.
31. Lieber MM, Murtaugh PA, Farrow GM, Myers RP, and Blute ML (1995). DNA ploidy and surgically treated prostate cancer. Cancer 75:1935-1943.
32. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, and Mitelman F (1992). Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosom Cancer 4:16-24.
33. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell I-J, and Pontes JE (1994). Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 54:3824-3830.
34. Mantel N (1963). Chi square test with one degree of freedom. J Am Stat Assoc 58:690-700.
35. Matsuyama H, Pan Y, Skoog L, Tribukait B, Naito K, Ekman P, Lichter P, and Bergerheim USR (1994). Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene 9:3071-3076.
36. Noordzij MA, van Weerden WM, de Ridder CMA, van der Kwast TH, Schröder FH, and van Steenbrugge GJ (1996). Neuroendocrine differentiation in human prostatic tumor models. Am J Pathol 149:859-871.
37. Persons DL, Takai K, Gibney DJ, Lieber MM, and Jenkins RB (1994). Comparison of fluorescence in situ hybridization with flow cytometry and static image analysis in ploidy analysis of paraffin-embedded prostate adenocarcinoma. Hum Pathol 25:678-693.
38. Pisters LL, Troncoso P, Zhau HE, Li W, von Eschenbach AC, and Chung LWK (1995). c-met proto-oncogene expression in benign and malignant human prostate tissues. J Urol 154: 293-298.
39. Scardino PT, Weaver R, and Hudson MA (1992). Early detection of prostate cancer. Hum Pathol 23:211-222.
40. Schröder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, and Pavone-Macaluso M (1992). The TNM classification of prostate cancer. Prostate 4(Suppl):129-138.
41. Smith JR, Freije D, Carpten JD, Grönberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovsky P, Nusskern DR, Damber J-E, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FC, Trent JM, and Isaacs WB (1996). Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274:1371-1374.
42. Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, and Jenkins RB (1994). Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res 54:3574-3579.
43. Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN, and Jenkins RB (1995). Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res 55:4114-4119.
44. Trapman J, Sleddens HFBM, van der Weiden MM, Dinjens WNM, König JJ, Schröder FH, Faber PW, and Bosman FT (1994). Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 54:6061-6064.
45. Van Dekken H, Kerstens HMJ, Tersteeg TA, Verhofstad AAJ, and Vooijs GP (1992). Histological preservation after in situ hybridization to archival solid tumor sections allows discrimination of cells bearing numerical changes. J Pathol 168:317-324.
46. Van den Berg C, Guan X-Y, Von Hoff D, Jenkins R, Bittner M, Griffin C, Kallioniemi O, Visakorpi T, McGill J, Herath J, Epstein J, Sarosy M, Meltzer P, and Trent J (1995). DNA sequence amplification in human prostate cancer identified by chromosome microdissection: Potential prognostic implications. Clin Cancer Res 1:11-18.
47. Van Driel-Kulker AMJ, Eysackers MJ, Dessing MTM, and Ploem JS (1986). A simple method to select specific tumor areas in paraffin blocks for cytometry using incident fluorescence microscopy. Cytometry 7:601-604.
48. Van den Ouden D, Tribukait B, Blom JHM, Fossa SD, Kurth KH, ten Kate FJW, Heiden T, Wang N, Schröder FH, and the European Organization for Research and Treatment of Cancer Genitourinary Group (1993). Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: Impact on time to progression. J Urol 150:400-406.
49. Van Weerden WM, de Ridder CMA, Verdaasdonk CL, Romijn JC, van der Kwast ThH, Schröder FH, and van Steenbrugge GJ (1996). Development of seven new human prostate tumor xenograft models and their histopathological characterization. Am J Pathol 149:1055-1062.
50. Visakorpi T, Kallioniemi AH, Syvänen A-C, Hyytinen ER, Karhu R, Tammela T, Isola JJ, and Kallioniemi O-P (1995). Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
51. Vocke CD, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, Duray PH, Liotta LA, Emmert-Buck MR, and Linehan WM (1996). Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res 56:2411-2416.
52. Waldman FM, Carroll PR, Kerschmann R, Cohen MB, Field FG, and Mayall BH (1991). Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res 51: 3807-3813.
53. Wood DP, Banks ER, Humphreys S, McRoberts JW, and Rangnekar VM (1994). Identification of bone marrow micrometastases in patients with prostate cancer. Cancer 74: 2533-2540.